¼¼°èÀÇ ¿ø°Ý Á¤½ÅÀÇÇÐ ½ÃÀå
Telepsychiatry
»óǰÄÚµå : 1739382
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 187 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,118,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,355,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¿ø°Ý Á¤½ÅÀÇÇÐ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 314¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 104¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¿ø°Ý Á¤½ÅÀÇÇÐ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 20.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 314¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ °¡Á¤³» ¼Ö·ç¼ÇÀº CAGR 18.2%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 128¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Æ÷·»½Ä ¼Ö·ç¼Ç ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 20.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 27¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 19.3%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿ø°Ý Á¤½ÅÀÇÇÐ ½ÃÀåÀº 2024³â¿¡ 27¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 48¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 19.3%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 18.4%¿Í 17.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 15.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¿ø°Ý Á¤½ÅÀÇÇÐ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿ø°Ý Á¤½ÅÀÇÇÐÀÌ Á¤½Å°Ç°­ °ü¸®ÀÇ Á¢±Ù¼º, ¿¬¼Ó¼º, ÇüÆò¼ºÀ» ÀçÁ¤ÀÇÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

¿ø°Ý Á¤½ÅÀÇÇÐ(¿ø°Ý Åë½Å ±â¼úÀ» ÅëÇÑ Á¤½Å°úÀû Æò°¡, Ä¡·á, ¾à¹° °ü¸®, »ó´ã Á¦°ø)Àº Á¤½Å°Ç°­ ¼­ºñ½º Á¢±Ù ¹× Á¦°ø ¹æ½ÄÀ» º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ƯÈ÷ ³óÃÌ Áö¿ªÀ̳ª ¼Ò¿ÜµÈ Áö¿ª, ¶Ç´Â ³«ÀÎÀÌ ÂïÈù »ç¶÷µé¿¡¼­ ȯÀÚ¿Í ¸éÇ㸦 °¡Áø Á¤½Å°ú Àǻ縦 ½Ç½Ã°£ ¶Ç´Â ºñµ¿½ÃÀûÀ¸·Î ¿¬°áÇÏ¿© Ä¡·á¿¡ ´ëÇÑ Áö¸®Àû, ¹°·ùÀû À庮À» Á¦°ÅÇÕ´Ï´Ù. ¿ø°Ý Á¤½ÅÀÇÇÐÀº À̵¿ÀÇ ¾î·Á¿ò, ±³Åë¼ö´ÜÀÇ Á¦ÇÑ, ÀÇ·á ¼­ºñ½º Á¦°øÀÚ ºÎÁ·¿¡ Á÷¸éÇÑ »ç¶÷µé¿¡°Ô Àû½Ã¿¡ Á¤½Å°ú ÀÇ·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Å©°Ô Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

¿ø°Ý Á¤½ÅÀÇÇÐÀº Á¢±Ù¼º»Ó¸¸ ¾Æ´Ï¶ó Á¤±âÀûÀÎ ÈÄ¼Ó Á¶Ä¡, ¾à¹° ¸ð´ÏÅ͸µ, ÀÇ·á ½Ã½ºÅÛÀ» ³Ñ¾î¼± ´ÙÇÐÁ¦Àû Ä¡·á Á¶Á¤À» °¡´ÉÇϰÔÇÔÀ¸·Î½á Ä¡·áÀÇ ¿¬¼Ó¼ºÀ» Áö¿øÇÕ´Ï´Ù. ¿ø°Ý Á¤½ÅÀÇÇÐÀº ¶ÇÇÑ µµ½Ã Áö¿ªÀÇ ½ºÆ®·¹½º, ºÐÀï, °æÁ¦Àû ºÒÈ®½Ç¼º, °øÁß º¸°Ç À§±â·Î ÀÎÇØ ¾ÇÈ­µÇ´Â Á¤½Å°Ç°­ »óÅÂÀÇ ºÎ´ã Áõ°¡¿¡ ´ëóÇÏ´Â µ¥¿¡µµ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î Á¤½Å°Ç°­ÀÌ °øÁߺ¸°ÇÀÇ ÃÖ¿ì¼± °úÁ¦·Î ¶°¿À¸£¸é¼­ ¿ø°Ý Á¤½ÅÀÇÇÐÀº È®Àå °¡´ÉÇÑ È¯ÀÚ Á᫐ ¼Ö·ç¼ÇÀ¸·Î ÀÏÂ÷ÀÇ·á, ±³Á¤½Ã¼³, Çб³, ÀÀ±Þ½Ç µî¿¡ Á¦µµÈ­µÇ°í ÀÖ½À´Ï´Ù.

µðÁöÅÐ Ç÷§Æû, Áø·áºñ Á¤Ã¥, ¶óÀ̼±½º °³ÇõÀº ¾î¶»°Ô µµÀÔÀ» °¡¼ÓÈ­Çϰí Àִ°¡?

HIPAA¸¦ ÁؼöÇÏ´Â È­»ó ȸÀÇ µµ±¸, ¾ÈÀüÇÑ È¯ÀÚ Æ÷ÅÐ, ÅëÇÕ EHR(ÀüÀÚÀǹ«±â·Ï) ½Ã½ºÅÛÀÇ ±Þ¼ÓÇÑ ¹ßÀüÀ¸·Î ¿ø°Ý Á¤½ÅÀÇÇÐÀº ±â¼úÀûÀ¸·Î ½ÇÇö °¡´ÉÇϰí ÀÓ»óÀûÀ¸·Îµµ È¿°úÀûÀÏ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀº ¸ÂÃãÇü ÀÎÅÍÆäÀ̽º, ´Ù±¹¾î Áö¿ø, ¼¼¼Ç ±â·Ï, ¿ø°Ý ó¹æ ±â´ÉÀ» Á¦°øÇÔÀ¸·Î½á ÀÇ·á Á¦°øÀÚ¿Í È¯ÀÚ ¸ðµÎ¿¡°Ô ´õ ³ªÀº »ç¿ë ÆíÀǼºÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µðÁöÅÐ °­È­´Â ¿ø°Ý Á¤½ÅÀÇ·á ¼­ºñ½ºÀÇ ÆøÀ» ³ÐÇô ±×·ì Ä¡·á, Çൿ °Ç°­ ÄÚĪ, Çù¾÷ ÄÉ¾î ¸ðµ¨ µîÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù.

ƯÈ÷ COVID-19 ÀÌÈÄ Á¤Ã¥ º¯È­·Î ÀÎÇØ ÀϺΠ±¹°¡¿¡¼­´Â º¸Çè »óȯÀÇ ÆòÁØÈ­¿Í ÁÖ¸¦ ³Ñ¾î¼± ¶óÀ̼±½º °³ÇõÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á¿¡ ´ëÇÑ ±ÔÁ¦°¡ ¿ÏÈ­µÇ¸é¼­ º¸Çè»ç ¹× Á¤ºÎ ÁöºÒ ±â°üÀº ¿ø°ÝÀ¸·Î Á¦°øµÇ´Â Á¤½Å°ú ÀÇ·á ¼­ºñ½º¸¦ º¸ÀåÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ÀÓ»ó¿¡¼­ ³Î¸® µµÀԵǰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦ º¯È­´Â Á¤½Å°Ç°­¿¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡¿Í ÇÔ²² ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀÌ ¿ø°Ý Á¤½ÅÀÇÇÐ ÀÎÇÁ¶ó¿¡ ÅõÀÚÇϰí ÁÖ·ù Çൿ ÀÇÇÐ ¿öÅ©Ç÷ο쿡 ÅëÇÕÇÒ ¼ö ÀÖ´Â µ¿±â¸¦ ºÎ¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ö¿ä¸¦ ÁÖµµÇϴ ȯÀÚÃþ°ú ÇコÄɾî ȯ°æÀº?

¿ø°Ý Á¤½ÅÀÇÇÐ ¼­ºñ½º¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä´Â û¼Ò³â, »çȸÀÎ, ³ëÀÎÃþ¿¡¼­ ³ªÅ¸³³´Ï´Ù. ÀþÀº ÃþÀº µðÁöÅп¡ Àͼ÷Çϰí À¯¿¬ÇÏ´Ù´Â ÀåÁ¡ÀÌ ÀÖ°í, °í·ÉÀÇ È¯ÀÚ³ª ¸¸¼º Á¤½ÅÁúȯÀ» ¾Î°í Àִ ȯÀÚµéÀº ÀϰüµÈ Á¢Ã˰ú ³«Àΰ¨À» ÁÙÀÏ ¼ö ÀÖ´Ù´Â ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ¿ø°Ý Á¤½ÅÀÇÇÐÀº ±Þ¼º ¿¡ÇǼҵåÀÇ ¿ÏÈ­ ¹× Á¶±â Ä¡·á ½ÃÀÛÀ» À§ÇØ ½Å¼ÓÇÑ Á¤½Å°úÀû Æò°¡°¡ ÇʼöÀûÀÎ À§±â °³ÀÔ È¯°æ¿¡¼­µµ ³Î¸® äÅõǰí ÀÖ½À´Ï´Ù.

¿Ü·¡Áø·á¼Ò, º´¿ø, ±³Á¤½Ã¼³, Çб³, Àå±â¿ä¾ç½Ã¼³ µîÀÇ ÇコÄÉ¾î ½Ã½ºÅÛÀº Àη ºÎÁ·À» ÇØ°áÇÏ°í ¼­ºñ½º ¹üÀ§¸¦ °³¼±Çϱâ À§ÇØ ¿ø°Ý Á¤½ÅÀÇÇÐÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. ÀÏÂ÷ Áø·á¿¡¼­´Â Á¤½Å°ú Áø·á¸¦ ¿¬°è Áø·á ¸ðµ¨¿¡ ÅëÇÕÇÏ¿© µ¿¹Ý ÁúȯÀ» Á¾ÇÕÀûÀ¸·Î ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ »ç¿ë »ç·Ê´Â ¿ø°Ý Á¤½ÅÀÇÇÐÀÌ ´Ü¼øÈ÷ ÆÒµ¥¹ÍÀ» ÇÇÇϱâ À§ÇÑ ¼ö´ÜÀ¸·Î¼­°¡ ¾Æ´Ï¶ó Çö´ë Á¤½ÅÀÇÇÐ Á¦°ø¿¡ ÀÖ¾î ¿µ±¸ÀûÀÎ ½Ã¼³·Î Àνĵǰí ÀÖÀ½À» °­Á¶ÇÕ´Ï´Ù.

ÀÓ»ó °á°ú, ÇÁ¶óÀ̹ö½Ã ÇÁ·ÎÅäÄÝ, ÀÇ·áÁøÀÇ ¿öÅ©Ç÷οì, ±¸Çö Àü·«ÀÌ ¾î¶»°Ô ±¸Çö Àü·«À» Çü¼ºÇϰí Àִ°¡?

¿ø°Ý Á¤½ÅÀÇÇÐÀº ¿ì¿ïÁõ, ºÒ¾ÈÀå¾Ö, PTSD, ¾ç±Ø¼º Àå¾Ö¿Í °°Àº Áõ»ó¿¡¼­ ´ë¸é Áø·á¿¡ ÇÊÀûÇÏ´Â ÀÓ»óÀû °á°ú¸¦ °¡Á®¿Â´Ù´Â Áõ°Å°¡ °è¼Ó ³ª¿À°í ÀÖ½À´Ï´Ù. ³ôÀº ȯÀÚ ¸¸Á·µµ, ¹«´Ü°á¼®·ü °¨¼Ò, º¹¾à ¼øÀÀµµ Áõ°¡´Â ¿ø°Ý Á¤½ÅÀÇÇÐÀÇ ¿µ±¸ÀûÀÎ ÅëÇÕÀ» ÁöÁöÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ƯÈ÷ ¹Ì¼º³âÀÚ Ä¡·á³ª ¹Î°¨ÇÑ Çൿ ÀÇ·á ±â·ÏÀ» °ü¸®ÇÒ ¶§´Â ÇÁ¶óÀ̹ö½Ã, »çÀü µ¿ÀÇ, µ¥ÀÌÅÍ º¸È£¿¡ ´ëÇÑ ´ëÀÀÀÌ ÇÊ¿äÇÕ´Ï´Ù.

¿öÅ©Ç÷οì ÅëÇÕÀº Á¤½Å°ú Àǻ簡 ȯÀÚÀÇ ºÎ´ãÀ» È¿À²ÀûÀ¸·Î °ü¸®Çϱâ À§ÇØ ½ºÄÉÁÙ¸µ Áö¿ø, »óÈ£ ¿î¿ë °¡´ÉÇÑ ¹®¼­È­ ½Ã½ºÅÛ, À¯¿¬ÇÑ Ç÷§ÆûÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ ¶Ç ´Ù¸¥ ÁßÁ¡ ºÐ¾ßÀÔ´Ï´Ù. µµÀÔÀ» È®´ëÇϱâ À§Çؼ­´Â ÀÇ·áÁø ±³À°, º¯°æ °ü¸®, ±â¼ú Áö¿øÀÌ ÇʼöÀûÀÔ´Ï´Ù. ´ë¸é Áø·á¿Í °¡»ó Áø·á°¡ °áÇÕµÈ ÇÏÀ̺긮µå ¸ðµ¨ÀÌ ÁÖ·ù°¡ µÇ°í ÀÖÀ¸¸ç, ÀÇ·áÁøÀº ÀÓ»óÀû Çʿ信 µû¶ó Áø·á ¼öÁØÀ» ºÐ·ùÇϸ鼭 ´Ù¾çÇÑ Áø·á ȯ°æ¿¡¼­ Âü¿©¿Í Ä¡·áÀÇ ¿¬¼Ó¼ºÀ» À¯ÁöÇÒ ¼ö ÀÖ½À´Ï´Ù.

¿ø°Ý Á¤½ÅÀÇÇÐ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¿ø°Ý Á¤½ÅÀÇÇÐ ½ÃÀåÀº Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ Á¤½Å°Ç°­¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ¿ì¼±½ÃÇϰí, ±â¼ú µµÀÔÀÌ °¡¼ÓÈ­µÇ°í, ȯÀÚµéÀÇ ¼±È£µµ°¡ Æí¸®ÇÔ°ú ÀÍ¸í¼ºÀ¸·Î À̵¿ÇÔ¿¡ µû¶ó ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. º¸Çè »óȯ, ¸éÇãÀÇ À¯¿¬¼º, µðÁöÅÐ ¸®ÅÍ·¯½Ã¿Í °°Àº ±¸Á¶Àû ¿äÀÎÀÌ ÀÌ·¯ÇÑ ¼ºÀå ±Ëµµ¿¡ ÈûÀ» ½Ç¾îÁÖ°í ÀÖÀ¸¸ç, Àα¸ Ãß¼¼¿Í Á¤½Å°ú ȯÀÚ ¼öÀÇ Áõ°¡´Â ¼­ºñ½º ¼ö¿ä¸¦ Áö¼ÓÀûÀ¸·Î Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¿ø°Ý Á¤½ÅÀÇÇÐÀº °ø°ø ¹× ¹Î°£ ÀÇ·á ½Ã½ºÅÛ ¸ðµÎ¿¡¼­ È®Àå °¡´ÉÇÏ°í °øÆòÇÑ Çൿ Ä¡·á Àü·«ÀÇ ÇÙ½ÉÀ¸·Î Á¡Á¡ ´õ ¸¹ÀÌ Àνĵǰí ÀÖ½À´Ï´Ù.

¾ÕÀ¸·ÎÀÇ ¼ºÀåÀº Á¦°øÀÚ, ÁöºÒÀÚ, Á¤Ã¥ ÀÔ¾ÈÀÚµéÀÌ ±ÔÁ¦Àû Áö¿øÀ» È¿°úÀûÀ¸·Î À¯ÁöÇϰí, Ç÷§ÆûÀÇ »óÈ£¿î¿ë¼º¿¡ ÅõÀÚÇϸç, ¼Ò¿ÜµÈ Áö¿ª»çȸÀÇ µðÁöÅÐ °ÝÂ÷¸¦ ÇØ¼ÒÇÏ´Â µ¥¿¡ ´Þ·ÁÀÖ½À´Ï´Ù. ¿ø°Ý Á¤½ÅÀÇÇÐÀÌ ¿ÏÀüÈ÷ ÅëÇյǰí, ¹®È­Àû ¿ª·®ÀÌ ÀÖÀ¸¸ç, °á°ú Áß½ÉÀûÀÎ ¾ç»óÀ¸·Î ÁøÈ­ÇÒ ¼ö ÀÖ´ÂÁö ¿©ºÎ°¡ Àü ¼¼°è Á¤½Å°Ç°­ °ü¸®ÀÇ ¹Ì·¡¸¦ °áÁ¤ÇÏ´Â µ¥ ÀÖ¾î ¿ø°Ý Á¤½ÅÀÇÇÐÀÌ Àå±âÀûÀ¸·Î ¾î¶² ¿ªÇÒÀ» ÇÒ ¼ö ÀÖÀ»Áö °áÁ¤ÇÏ°Ô µÉ °ÍÀÔ´Ï´Ù.

ºÎ¹®

Á¦Ç°(ÀçÅà ¼Ö·ç¼Ç, ¹ýÀÇÇÐ ¼Ö·ç¼Ç, ÀÏ»ó ¼Ö·ç¼Ç, À§±â °ü¸® ¼Ö·ç¼Ç, ±âŸ Á¦Ç°), ¿¬·ÉÃþ(¼ºÀÎ, ¼Ò¾Æ¡¤Ã»¼Ò³â±â, ³ëÀÎ), ÃÖÁ¾»ç¿ëÀÚ(Áö¿ª Á¤½Å º¸°Ç ¼¾ÅÍ, Àü¹®ÀÇ·á½Ã¼³, ¿ä¾ç½Ã¼³, ÀçÅà Äɾî, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 47°³»ç)

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ÀÎÀ§ÀûÀÎ ¸ÅÃâ¿ø°¡ Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Global Industry Analysts´Â ¼¼°è ÁÖ¿ä ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ®(1,4,949¸í), ½ÌÅ©ÅÊÅ©(62°³ ±â°ü), ¹«¿ª ¹× »ê¾÷ ´Üü(171°³ ±â°ü)ÀÇ Àü¹®°¡µéÀÇ ÀǰßÀ» ¸é¹ÐÈ÷ °ËÅäÇÏ¿© »ýŰ迡 ¹ÌÄ¡´Â ¿µÇâÀ» Æò°¡ÇÏ°í »õ·Î¿î ½ÃÀå Çö½Ç¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ¸ðµç ÁÖ¿ä ±¹°¡ÀÇ Àü¹®°¡¿Í °æÁ¦ÇÐÀÚµéÀÌ °ü¼¼¿Í ±×°ÍÀÌ ÀÚ±¹¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀǰßÀ» ÃßÀû Á¶»çÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀÌ·¯ÇÑ È¥¶õÀÌ ÇâÈÄ 2-3°³¿ù ³»¿¡ ¸¶¹«¸®µÇ°í »õ·Î¿î ¼¼°è Áú¼­°¡ º¸´Ù ¸íÈ®ÇÏ°Ô È®¸³µÉ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖÀ¸¸ç, Global Industry Analysts´Â ÀÌ·¯ÇÑ »óȲÀ» ½Ç½Ã°£À¸·Î ÃßÀûÇϰí ÀÖ½À´Ï´Ù.

2025³â 4¿ù : Çù»ó ´Ü°è

À̹ø 4¿ù º¸°í¼­¿¡¼­´Â °ü¼¼°¡ ¼¼°è ½ÃÀå Àüü¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú Áö¿ªº° ½ÃÀå Á¶Á¤¿¡ ´ëÇØ ¼Ò°³ÇÕ´Ï´Ù. ´ç»çÀÇ ¿¹ÃøÀº °ú°Å µ¥ÀÌÅÍ¿Í ÁøÈ­ÇÏ´Â ½ÃÀå ¿µÇâ¿äÀÎÀ» ±â¹ÝÀ¸·Î ÇÕ´Ï´Ù.

2025³â 7¿ù : ÃÖÁ¾ °ü¼¼ Àç¼³Á¤

°¢±¹ÀÇ ÃÖÁ¾ ¸®¼ÂÀÌ ¹ßÇ¥µÇ´Â 7¿ù¿¡µµ °í°´´Ôµé²² ¹«·á ¾÷µ¥ÀÌÆ®¸¦ Á¦°øÇÒ ¿¹Á¤ÀÔ´Ï´Ù. ÃÖÁ¾ ¾÷µ¥ÀÌÆ® ¹öÀü¿¡´Â ¸íÈ®ÇÏ°Ô Á¤ÀÇµÈ °ü¼¼ ¿µÇ⠺м®ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

»óÈ£ ¹× ¾çÀÚ °£ ¹«¿ª°ú °ü¼¼ÀÇ ¿µÇ⠺м®:

¹Ì±¹ <> Áß±¹ <> ¸ß½ÃÄÚ <> ij³ª´Ù <> EU <> ÀϺ» <> Àεµ <> ±âŸ 176°³±¹

¾÷°è ÃÖ°íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ® : Global Industry AnalystsÀÇ Áö½Ä ±â¹ÝÀº ±¹°¡, ½ÌÅ©ÅÊÅ©, ¹«¿ª ¹× »ê¾÷ ´Üü, ´ë±â¾÷, ±×¸®°í ¼¼°è °è·® °æÁ¦ »óȲÀÇ Àü·Ê ¾ø´Â ÆÐ·¯´ÙÀÓ ÀüȯÀÇ ¿µÇâÀ» °øÀ¯ÇÏ´Â ºÐ¾ßº° Àü¹®°¡ µî °¡Àå ¿µÇâ·Â ÀÖ´Â ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ Æ÷ÇÔÇÑ 14,949¸íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ ÃßÀûÇϰí ÀÖ½À´Ï´Ù. 16,491°³ ÀÌ»óÀÇ º¸°í¼­ ´ëºÎºÐ¿¡ ¸¶ÀϽºÅæ¿¡ ±â¹ÝÇÑ 2´Ü°è Ãâ½Ã ÀÏÁ¤ÀÌ Àû¿ëµÇ¾î ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Telepsychiatry Market to Reach US$31.4 Billion by 2030

The global market for Telepsychiatry estimated at US$10.4 Billion in the year 2024, is expected to reach US$31.4 Billion by 2030, growing at a CAGR of 20.3% over the analysis period 2024-2030. In-home Solutions, one of the segments analyzed in the report, is expected to record a 18.2% CAGR and reach US$12.8 Billion by the end of the analysis period. Growth in the Forensic Solutions segment is estimated at 20.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 19.3% CAGR

The Telepsychiatry market in the U.S. is estimated at US$2.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 19.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.4% and 17.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.1% CAGR.

Global Telepsychiatry Market - Key Trends & Drivers Summarized

Why Is Telepsychiatry Redefining Access, Continuity, and Equity in Mental Health Care Delivery?

Telepsychiatry-the provision of psychiatric evaluation, therapy, medication management, and consultation via telecommunication technologies-is transforming how mental health services are accessed and delivered. It removes geographic and logistical barriers to care, especially in rural, underserved, or stigmatized populations, by connecting patients with licensed psychiatrists in real-time or asynchronously. For individuals facing mobility challenges, transportation limitations, or provider shortages, telepsychiatry significantly improves access to timely psychiatric intervention.

Beyond accessibility, telepsychiatry supports continuity of care by enabling regular follow-ups, medication monitoring, and coordinated multidisciplinary treatment across health systems. It also helps address the growing burden of mental health conditions exacerbated by urban stress, conflict, economic uncertainty, and public health crises. As mental health gains priority in global public health agendas, telepsychiatry is being institutionalized into primary care, correctional facilities, schools, and emergency departments as a scalable, patient-centric solution.

How Are Digital Platforms, Reimbursement Policies, and Licensing Reforms Accelerating Adoption?

The rapid advancement of HIPAA-compliant video conferencing tools, secure patient portals, and integrated EHR (Electronic Health Record) systems has made telepsychiatry technically feasible and clinically effective. Cloud-based platforms now offer customizable interfaces, multilingual support, session recording, and remote prescribing capabilities, improving usability for both providers and patients. These digital enhancements are expanding the range of telepsychiatric services and enabling group therapy, behavioral health coaching, and collaborative care models.

Policy changes-particularly during and post-COVID-19-have accelerated reimbursement parity and cross-state licensing reforms in several countries. The relaxation of telehealth restrictions has prompted insurers and government payers to cover psychiatric services delivered remotely, supporting widespread clinical adoption. These regulatory shifts, combined with growing mental health awareness, are incentivizing providers to invest in telepsychiatry infrastructure and integrate it into mainstream behavioral health workflows.

Which Patient Demographics and Healthcare Settings Are Driving Market Demand?

High demand for telepsychiatry services is seen among adolescents, working adults, and elderly patients-each facing unique access challenges that virtual care helps to mitigate. Younger populations benefit from digital familiarity and flexibility, while older patients and those with chronic mental illness gain from consistent contact and reduced stigma. Telepsychiatry is also widely adopted in crisis intervention settings, where rapid psychiatric assessment is essential to de-escalating acute episodes or initiating early treatment.

Healthcare systems, including outpatient clinics, hospitals, correctional institutions, schools, and long-term care facilities, are embedding telepsychiatry to address staffing shortages and improve service coverage. Primary care practices are integrating psychiatric consults into collaborative care models to address comorbidities more holistically. These use cases highlight the growing recognition of telepsychiatry not just as a pandemic workaround, but as a permanent fixture in modern mental health care delivery.

How Are Clinical Outcomes, Privacy Protocols, and Provider Workflows Shaping Implementation Strategies?

Evidence continues to show that telepsychiatry produces clinical outcomes comparable to in-person care across conditions such as depression, anxiety, PTSD, and bipolar disorder. High patient satisfaction rates, reduced no-show rates, and improved medication adherence support the case for permanent telepsychiatry integration. However, implementation must address privacy, informed consent, and data protection, especially when treating minors or managing sensitive behavioral health records.

Workflow integration is another focus area, as psychiatrists require scheduling support, interoperable documentation systems, and flexible platforms to manage patient loads efficiently. Provider training, change management, and technical support are essential to scale adoption. Hybrid models combining in-person and virtual care are becoming the norm, allowing providers to triage care levels based on clinical need while maintaining engagement and treatment continuity across diverse care settings.

What Are the Factors Driving Growth in the Telepsychiatry Market?

The telepsychiatry market is expanding as global health systems prioritize mental health access, technology adoption accelerates, and patient preferences shift toward convenience and anonymity. Structural enablers-such as insurance reimbursement, licensing flexibility, and digital literacy-are reinforcing this growth trajectory, while demographic trends and rising psychiatric caseloads continue to increase service demand. Telepsychiatry is increasingly recognized as a cornerstone of scalable, equitable behavioral health strategy in both public and private care systems.

Looking ahead, growth will hinge on how effectively providers, payers, and policymakers can sustain regulatory support, invest in platform interoperability, and bridge digital divides in marginalized communities. Whether telepsychiatry can evolve into a fully integrated, culturally competent, and outcomes-driven modality will determine its long-term role in shaping the future of global mental healthcare delivery.

SCOPE OF STUDY:

The report analyzes the Telepsychiatry market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (In-home Solutions, Forensic Solutions, Routine Solutions, Crisis Solutions, Other Products); Age Group (Adult, Pediatric & Adolescent, Geriatric); End-User (Community Mental Health Centers, Specialty Care Settings, Skilled Nursing Facilities, Homecare, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 47 Featured) -

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â